Verisign's Gen Counsel & Secretary sold $125K of Verisign shares. Nobody planned it ahead of time.
Traded Feb 27, 2026 · Filed Mar 4, 2026
A board member of Verisign paid $712 out of pocket for Verisign shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$712
Shares × reported transaction price
<$25K
+0.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 3 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 1 earlier confirmed purchase
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
22 days after results of Feb 5, 2026, 55 days before results of Apr 23, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $227.94 on Feb 27, 2026, 8% above its 52-week low and 26% below its high, after a 9% drop over the previous 30 trading days
52-week range $211.49 (Feb 23, 2026) to $305.98 (Jul 28, 2025), 17% of the way up, from 251 adjusted closes. 30 trading days earlier: $249.31 on Jan 14, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.3% | -1.3% | -0.0% |
| 30 days | +14.9% | -3.8% | +18.8% |
| 90 days | +24.5% | +10.9% | +13.7% |
| 180 days | +20.7% | +12.0% | +8.8% |
Past results only. Not a forecast.
Verisign's Gen Counsel & Secretary sold $125K of Verisign shares. Nobody planned it ahead of time.
A board member of Verisign paid $4K out of pocket for Verisign shares.
Verisign's Gen Counsel & Secretary sold $80K of Verisign shares. Nobody planned it ahead of time.
Courtney D Armstrong, Director's past purchases, 90 days after disclosure: 3 buys, median -3.9% vs S&P 500, beat it 1 of 3 times. Past results, not a forecast.